Actionnariat et activité des initiés pour Ardelyx, Inc. (ARDX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.39 |
| Capitalisation | $837M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-21 | Hohenleitner Susan | S-Sale | 1,558 | $6K |
| 2026-08-21 | Reilly Joseph James | S-Sale | 2,872 | $11K |
| 2026-08-21 | Reilly Joseph James | S-Sale | 1,110 | $4K |
| 2026-08-21 | Bishop John E | S-Sale | 17,281 | $67K |
| 2026-08-21 | Bishop John E | S-Sale | 2,469 | $10K |
| 2026-08-21 | Brady James Parker | S-Sale | 1,976 | $8K |
| 2026-08-21 | Brady James Parker | S-Sale | 13,160 | $51K |
| 2026-08-21 | Foster Eric Duane | S-Sale | 2,598 | $10K |
| 2026-08-21 | Foster Eric Duane | S-Sale | 3,389 | $13K |
| 2026-08-21 | Foster Eric Duane | S-Sale | 2,575 | $10K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $74.6M | $75.4M | $78.8M | $181.1M | $91.0M | $72.4M | $96.1M | $21.5M | $64.9M | $68.0M |
| Placements à Court Terme | $126.2M | $58.6M | $89.3M | $66.4M | $95.5M | $44.3M | $27.8M | $162.8M | $185.2M | $196.7M |
| Créances | 0 | $10.8M | $5.1M | $750000 | 0 | $502000 | $7.7M | $22.0M | $57.7M | $71.8M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | $3.3M | $12.4M | $21.2M | $17.7M |
| Actifs Courants | $204.0M | $149.9M | $177.7M | $252.4M | $195.2M | $133.6M | $153.6M | $246.1M | $356.5M | $382.3M |
| Immobilisations Corporelles | $9.0M | $8.0M | $5.6M | $7.4M | $4.2M | $15.1M | $10.5M | $6.6M | $3.9M | $7.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $213.1M | $157.9M | $183.3M | $259.8M | $201.6M | $149.9M | $190.1M | $297.6M | $435.8M | $501.6M |
| Dettes Fournisseurs | $5.6M | $3.9M | $1.1M | $2.2M | $5.6M | $4.3M | $10.9M | $11.1M | $16.0M | $19.2M |
| Dette à Court Terme | 0 | 0 | 0 | $3.8M | $6.3M | $32.3M | $26.7M | 0 | 0 | $1.5M |
| Passifs Courants | $19.2M | $17.9M | $17.7M | $22.2M | $28.4M | $52.8M | $65.6M | $50.4M | $77.8M | $88.6M |
| Dette à Long Terme | 0 | 0 | $49.2M | $48.8M | $46.6M | 0 | 0 | $49.8M | $150.9M | $206.5M |
| Passifs Totaux | $20.0M | $18.6M | $67.5M | $73.1M | $75.5M | $67.3M | $91.7M | $130.8M | $262.5M | $334.7M |
| Réserves | -$213.9M | -$278.2M | -$365.5M | -$460.5M | -$554.8M | -$712.9M | -$780.1M | -$846.2M | -$885.3M | -$946.9M |
| Capitaux Propres | $193.2M | $139.3M | $115.8M | $186.7M | $126.1M | $82.6M | $98.3M | $166.8M | $173.3M | $166.9M |
| Dette Totale | 0 | 0 | $49.2M | $57.3M | $55.4M | $45.5M | $36.5M | $56.0M | $153.4M | $211.6M |
| Dette Nette | -$200.8M | -$134.0M | -$118.9M | -$190.2M | -$131.0M | -$71.2M | -$87.4M | -$128.3M | -$96.7M | -$53.1M |
| Fonds de Roulement | $184.8M | $132.0M | $160.0M | $230.2M | $166.8M | $80.8M | $88.0M | $195.7M | $278.6M | $293.7M |
Santé financière
| Dette / Capitaux propres | 1.72 |
| Ratio de liquidité | 3.34 |
Rentabilité
| Rentabilité des capitaux propres | -36.00% |
| Rentabilité du capital investi | -7.96% |
| Rentabilité des actifs | -9.67% |
| Marge brute | 93.96% |
| Marge opérationnelle | -7.86% |
| Marge nette | -12.35% |
Entreprises liées: BCRX · MAZE · NTLA · PHVS · STOK · SYRE · TRVI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ARDX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions